Loading...
Assessing the Association of Targeted Therapy and Intracranial Metastatic Disease
IMPORTANCE: Targeted therapies have been hypothesized to prolong survival in the treatment of patients with intracranial metastatic disease (IMD) but, paradoxically, increase IMD incidence by improving systemic disease control and prolonging survival from the primary tumor. The real-world benefits o...
Na minha lista:
| Udgivet i: | JAMA Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8176387/ https://ncbi.nlm.nih.gov/pubmed/34081080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2021.1600 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|